BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02252263-completion@plaintrial.com
DTSTAMP:20261111T014749Z
DTSTART;VALUE=DATE:20171010
SUMMARY:A Phase I Open Label Study of the Safety and Tolerability of Elotuz
 umab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-9
 86015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma — esti
 mated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02252263
URL:https://plaintrial.com/trial/NCT02252263
END:VEVENT
END:VCALENDAR